This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lg Chem, Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Su Jin Yeo - Innovator in Genetic Obesity Treatment
Introduction
Su Jin Yeo is an accomplished inventor based in Seoul, South Korea. She is currently associated with LG Chem, Ltd., where she focuses on innovative solutions in the field of genetic obesity treatment. Despite having no granted patents to her name, her contributions to the field are noteworthy.
Latest Patent Applications
Su Jin Yeo has been involved in several significant patent applications. One of her latest applications is titled "Use of Melanocortin-4 Receptor Agonist in Preventing or Treating Rare Genetic Obesity Disease." This invention relates to the use of a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof for preventing or treating rare genetic obesity diseases associated with a damaged melanocortin-4 receptor (MC4R) pathway, particularly those associated with proopiomelanocortin (POMC) deficiency. Another application is titled "Uses of Melanocortin-4 Receptor Agonist," which also focuses on the prevention and treatment of rare genetic obesity diseases linked to the MC4R pathway.
Conclusion
Su Jin Yeo is a promising inventor whose work in genetic obesity treatment holds potential for significant advancements in healthcare. Her innovative approaches may pave the way for future breakthroughs in the field.